Assessing Patient Preferences for Atopic Dermatitis Treatment: A Review Article of Discrete Choice Experiments.
Journal
Journal of drugs in dermatology : JDD
ISSN: 1545-9616
Titre abrégé: J Drugs Dermatol
Pays: United States
ID NLM: 101160020
Informations de publication
Date de publication:
01 Oct 2024
01 Oct 2024
Historique:
medline:
4
10
2024
pubmed:
4
10
2024
entrez:
3
10
2024
Statut:
ppublish
Résumé
Atopic dermatitis (AD) is one of the most prevalent inflammatory skin conditions, characterized by recurrent eczema with varying degrees of erythema, pruritus, xerosis, and pain. Although there are many treatment options for AD, efficacy is limited by poor adherence, especially for topical medications. Patient preferences for certain vehicle formulations and frequencies of administration, as well as patient aversion to certain adverse effects, can negatively impact adherence and treatment success. Discrete choice experiments (DCEs) are used to assess preferences in a manner comparable to clinical decision-making. Six discrete choice experiments on AD were analyzed to create a comprehensive data sheet of patient and physician preferences for medication. When choosing a medication, skin clearance, itch relief, and flexible treatments were most important to patients. J Drugs Dermatol. 2024;23(10):847-851. doi:10.36849/JDD.8056.
Identifiants
pubmed: 39361693
pii: S1545961624P8056X
doi: 10.36849/JDD.2024.8056
doi:
Substances chimiques
Dermatologic Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM